A Comprehensive Analysis of Parkinson’s Disease: Symptoms, Causes, and Scientific Management

By: Kevin Anderson

5 Minute read

Category: health

Core Symptoms: Dual Distress of Motor and Non-Motor Functions

Parkinson's disease is a chronic, progressive neurodegenerative disease that primarily affects motor function, but its effects go far beyond simple hand tremors. Typical motor symptoms can be summarized as "shaking, slowing, rigidity, and falling"—resting tremor, where the hands, legs, or jaw involuntarily tremble when relaxed, lessening during activity; bradykinesia, where movements become slower, difficulty starting and turning, and handwriting becomes increasingly smaller; rigidity, where limbs become stiff like "lead pipes" or "gears," with resistance felt during movement; and postural instability, with later stages exhibiting hunchback, shuffling gait, and frequent falls. Furthermore, non-motor symptoms also impact quality of life, sometimes appearing earlier, including decreased sense of smell, chronic constipation, shouting or kicking during sleep (REM sleep behavior disorder), depression and anxiety, and cognitive decline. A combination of these symptoms requires a comprehensive assessment by a neurologist.

Core Symptoms: Dual Distress of Motor and Non-Motor Functions

The core pathological change in Parkinson's disease is the gradual death of dopamine-secreting neurons in the substantia nigra region of the brain, leading to a severe deficiency of dopamine, a "motor coordinator." However, the exact cause of neuronal death remains inconclusive, currently believed to be the result of a combination of genetic susceptibility and environmental factors. Approximately 5-10% of patients have a clear family history, and certain gene mutations increase the risk. Among environmental factors, long-term exposure to toxic substances such as pesticides, herbicides, and heavy metals may increase the risk, while smoking and caffeine intake are considered to have a protective effect in observational studies, but the mechanism is unclear. Age is the biggest risk factor, with a significantly increased incidence in people over 60 years of age. It is important to clarify that Parkinson's disease is not directly fatal; fatal complications include falls and infections. Furthermore, it is not a typical hereditary disease, and the vast majority of patients have no clear family history.

Scientific Treatment: Comprehensive Management for Improved Quality of Life

While Parkinson's disease is currently incurable, scientific treatment can significantly control symptoms and maintain quality of life. Treatment follows the principle of "comprehensive and multi-pronged approach." Drug therapy is the cornerstone, with levodopa (such as dopacarzine) being the core medication. This directly supplements the brain's lack of dopamine, offering rapid onset of action, but long-term use may lead to fluctuations in efficacy and dyskinesia. Other options include dopamine receptor agonists (such as pramipexole) and MAO-B inhibitors (such as selegiline), which must be individually adjusted by a doctor based on age, symptoms, and disease progression. Patients should never adjust the dosage themselves. Deep brain stimulation (DBS) is an important surgical procedure that modulates abnormal nerve signals through implanted electrodes, showing significant effectiveness in patients with poor drug control in the middle and late stages. Rehabilitation therapy is ongoing, including physical therapy to improve balance and gait, occupational therapy to maintain self-care, and speech therapy to address swallowing and speaking difficulties. Psychological support is equally indispensable, helping patients and their families cope with emotional issues. Regular medication, regular checkups, adherence to rehabilitation, and maintaining social interaction are key to living with Parkinson's disease.